How does the USPTO handle an untimely or inappropriate comment from a third party requester in inter partes reexamination?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. According to MPEP 2666.10, if a third party requester files…

Read More

Can papers filed untimely in inter partes reexamination be considered later in the proceedings?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. Yes, papers that were initially considered untimely and returned or…

Read More

How are unsigned papers handled in inter partes reexamination?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 9 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. Unsigned papers in inter partes reexamination are generally denied consideration…

Read More

What is the status of unpublished U.S. applications as prior art under pre-AIA 35 U.S.C. 102(e)?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. Unpublished U.S. applications can serve as prior art under pre-AIA…

Read More

What happens if all required fees are not paid when filing a supplemental examination request?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. If all required fees for supplemental examination are not paid…

Read More

How does WIPO Standard ST.26 define “unknown” or “other” nucleotides and amino acids?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. MPEP 2412.03(a) refers to WIPO Standard ST.26, which defines “unknown”…

Read More